Pancreatic Cancer Research

ResearcherSarah Cannon Research InstituteActive in the last 2 years

David Robert Spigel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3215-9465; OpenAlex author ID A5018054038. Sources: ClinicalTrials.gov.

Their work

Papers
4 (first author 0, last author 1)
Trials
1
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 trial · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial. Co-author DOI 10.1038/s41591-026-04283-z↗
  2. Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 St… Co-author DOI 10.1200/jco-25-00746↗
  3. A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1158/1078-0432.ccr-24-0499↗
  4. A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced o… Co-author DOI 10.1007/s10637-011-9687-4↗

Trials 1

  1. Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers Study chair NCT02318784↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nataliya Volodymyrivna Uboha · 2 shared papers, 2024–2026 · strength 0.37
  2. Zev A. Wainberg · 1 shared paper, 2026 · strength 0.22
  3. Eileen Mary O'Reilly · 1 shared paper, 2026 · strength 0.22
  4. Anwaar Saeed · 1 shared paper, 2026 · strength 0.22
  5. Nathan Bahary · 1 shared paper, 2026 · strength 0.22
  6. Susanna Varkey Ulahannan · 1 shared paper, 2026 · strength 0.22
  7. Shubham Pant · 1 shared paper, 2026 · strength 0.22
  8. Gulam Abbas Manji · 1 shared paper, 2026 · strength 0.22
  9. Paul E. Oberstein · 1 shared paper, 2026 · strength 0.22
  10. Michael James Overman · 1 shared paper, 2024 · strength 0.16
  11. Nick Pavlakis · 1 shared paper, 2024 · strength 0.16
  12. Mariano Ponz‐Sarvisé · 1 shared paper, 2024 · strength 0.16
  13. Niharika B. Mettu · 1 shared paper, 2024 · strength 0.16
  14. Adnan M. Nagrial · 1 shared paper, 2024 · strength 0.16
  15. Andrew L. Coveler · 1 shared paper, 2024 · strength 0.16
  16. Matthew J. Reilley · 1 shared paper, 2024 · strength 0.16
  17. Mark M. Zalupski · 1 shared paper, 2024 · strength 0.16
  18. Christos K Fountzilas · 1 shared paper, 2024 · strength 0.16
  19. Anne M. Noonan · 1 shared paper, 2024 · strength 0.16
  20. Wells A. Messersmith · 1 shared paper, 2024 · strength 0.16
  21. Teresa Mercade Macarulla · 1 shared paper, 2024 · strength 0.16
  22. Gyorgy Bodoky · 1 shared paper, 2012 · strength 0.03
  23. Niall Christopher Tebbutt · 1 shared paper, 2012 · strength 0.03
  24. Tudor–Eliade Ciuleanu · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.